Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. The information obtained using a R34 planning grant is intended to address issues that will prepare the protocol for successful implementation and completion. Development of this R34 mechanism is meant to fill a gap in cancer prevention and control trials.

National Institutes of Health (NIH)

The following entities are eligible to apply for this funding opportunity: 1. Higher Education Institutions 2. Nonprofits Other Than Institutions of Higher Education 3. For-Profit Organizations: Small Businesses; For-Profit Organizations (Other than Small Businesses) 4. Local Governments 5.Federal Government 6. Other 7. Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. 8. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Applicant organizations may submit more than one application, provided that each application is scientifically distinct. It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from NIH Guide for Grants and Contracts).

When multiple years are involved, recipients will be required to submit the Research Performance Progress Report (RPPR) annually and financial statements as required in the NIH Grants Policy Statement. A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement.

Not Identifiable